CG
LABD icon

Cutler Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Cutler Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5K Sell
450
-18,470
-98% -$1.54M ﹤0.01% 1564
2023
Q4 		$103K Buy
18,920
+14,560
+334% +$2.83M 0.01% 1043
2023
Q3 		$92K Sell
4,360
-420
-9% -$68.2K 0.01% 1161
2023
Q2 		$36K Sell
4,780
-330
-6% -$49.3K 0.01% 1502
2023
Q1 		$140K Buy
5,110
+330
+7% +$56.1K 0.01% 837
2022
Q4 		$73K Buy
4,780
+470
+11% +$96.3K 0.01% 1349
2022
Q3 		$328K Sell
4,310
-1,450
-25% -$337K 0.02% 717
2022
Q2 		$195K Buy
5,760
+4,500
+357% +$2.26M 0.01% 1027
2022
Q1 		$56K Sell
1,260
-2,480
-66% -$972K ﹤0.01% 2152
2021
Q4 		$108K Sell
3,740
-1,740
-32% -$400K ﹤0.01% 1791
2021
Q3 		$80K Buy
5,480
+1,460
+36% +$311K ﹤0.01% 2107
2021
Q2 		$19K Sell
4,020
-1,060
-21% -$238K ﹤0.01% 3347
2021
Q1 		$49K Buy
5,080
+320
+7% +$62K ﹤0.01% 2412
2020
Q4 		$29K Buy
4,760
+680
+17% +$259K ﹤0.01% 2389
2020
Q3 		$35K Buy
4,080
+3,858
+1,738% +$2.49M ﹤0.01% 2040
2020
Q2 		$8K Sell
222
-163
-42% -$205K ﹤0.01% 3019
2020
Q1 		$231K Sell
385
-263
-41% -$750K 0.01% 866
2019
Q4 		$59K Sell
648
-87
-12% -$309K ﹤0.01% 1509
2019
Q3 		$622K Buy
735
+286
+64% +$1.18M 0.06% 305
2019
Q2 		$128K Buy
449
+140
+45% +$590K 0.01% 963
2019
Q1 		$64K Buy
309
+222
+255% +$1.08M 0.01% 1270
2018
Q4 		$35K Buy
87
+6
+7% +$44K ﹤0.01% 1705
2018
Q3 		$5K Sell
81
-1
-1% -$4.83K ﹤0.01% 3050
2018
Q2 		$25K Buy
82
+30
+58% +$182K ﹤0.01% 2033
2018
Q1 		$6K Buy
52
+15
+41% +$104K ﹤0.01% 3170
2017
Q4 		$5K Sell
37
-12
-24% -$120K ﹤0.01% 3627
2017
Q3 		$15K Buy
49
+16
+48% +$193K ﹤0.01% 3416
2017
Q2 		$43K Buy
33
+11
+50% +$211K ﹤0.01% 2651
2017
Q1 		$22K Buy
22
+2
+10% +$49.4K ﹤0.01% 3233
2016
Q4 		$162K Sell
20
-4
-17% -$154K 0.01% 1476
2016
Q3 		$118K Sell
24
-12
-33% -$561K 0.01% 1686
2016
Q2 		$318K Buy
36
+6
+20% +$484K 0.02% 827
2016
Q1 		$732K Buy
30
+14
+88% +$1.79M 0.05% 364
2015
Q4 		$216K Buy
+16
New +$1.22M 0.01% 1132

Other funds holding LABD

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ASM
AI-Squared Management Hong Kong $137M AUM 102.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Cutler Group's LABD Position: Q1 2024 in Review

Cutler Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2024, closing a stake of 10 shares — an estimated $834 sold.

Cutler Group first reported a position in LABD in Q1 2016 and held it in 23 quarters. The position peaked at $405K in Q2 2021. 21 funds tracked by Wall St. Rank hold LABD as of Q1 2024.

  • Cutler Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 10 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2024, an estimated $834.
  • Cutler Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 23 quarters.
  • Cutler Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $405K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.